RIO DE JANEIRO, BRAZIL - Brazil’s São Paulo state is expecting to receive on Wednesday, February 3rd, ingredients from Sinovac Biotech Ltd that will allow local production of 8.6 million doses of COVID-19 vaccine, the state government said in a statement on Sunday.
The ingredients are in Beijing’s airport, in China, awaiting discharge and will be used by São Paulo’s state-funded Butantan Institute, which has a partnership with Sinovac to produce the vaccines in Brazil . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here